| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/26/2006 | US7112592 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 09/26/2006 | US7112582 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics |
| 09/26/2006 | US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 09/26/2006 | US7112565 Stabilized pharmaceutical composition in lyophilized form |
| 09/26/2006 | US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents |
| 09/26/2006 | US7112415 Method of preparing cell cultures from biological specimens for assaying a response to an agent |
| 09/26/2006 | US7112414 Masp-2, a complement-fixing enzyme, and uses for it |
| 09/26/2006 | CA2536501C Crystal forms of azithromycin |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/26/2006 | CA2279317C O-sulfated bacterial polysaccharides |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006099376A1 Dragon's blood anti-viral materials and methods |
| 09/21/2006 | WO2006099374A1 Antiviral compositions and methods of use |
| 09/21/2006 | WO2006099325A2 Methods of treating ear infections |
| 09/21/2006 | WO2006098624A2 Anti-viral use of a coumarin agent |
| 09/21/2006 | WO2006098463A1 Polynucleic acid-binding substance |
| 09/21/2006 | WO2006097854A1 Heterodimeric meganucleases and use thereof |
| 09/21/2006 | WO2006097848A1 Hiv-1 virion maturation inhibitors, compositions and treatments using the same |
| 09/21/2006 | WO2006097689A2 Antibodies against candida antigens |
| 09/21/2006 | WO2006097273A1 Compounds having immunomodulator activity |
| 09/21/2006 | WO2006097258A1 The use of n-butylbenzenesulphonamide as an antimicrobial agent |
| 09/21/2006 | WO2006097030A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 09/21/2006 | WO2006096995A1 Sulfur oligonucleotides having antiviral activities |
| 09/21/2006 | WO2006096937A1 Use of copper silicate for the control of herpes infections |
| 09/21/2006 | WO2006084141A3 Suspension formulation of interferon |
| 09/21/2006 | WO2006072348A3 Alkinyl-substituted thiophenes |
| 09/21/2006 | WO2006065590A3 Pyridine and pyrimidine antiviral compositions |
| 09/21/2006 | WO2006060712A3 Potassium salt of an hiv integrase inhibitor |
| 09/21/2006 | WO2006043182A3 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 09/21/2006 | WO2006035066A3 Toll-like receptor 3, its signalling associated molecule trif and their use in the prevention and treatment of host inflammation response induced by a rna virus |
| 09/21/2006 | WO2006002422A9 Compounds for immunopotentiation |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | WO2005046730A3 Biotin-facilitated transport into gram negative bacteria |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060212109 Delivery of therapeutic capable agents |
| 09/21/2006 | US20060211855 Method for the production of oh protected{4-(2.6-diamino-9h-purine-9-yl)-1.3-dioxolane-2-yl] methanol derivatives |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211748 Sulphydryl compounds in combination with sulpha compounds |
| 09/21/2006 | US20060211732 Hydroxamic acid derivatives as antibacterials |
| 09/21/2006 | US20060211727 Novel compounds |
| 09/21/2006 | US20060211724 Hiv integrase inhibitors |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211654 Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor |
| 09/21/2006 | US20060211637 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 09/21/2006 | US20060211636 Macrolide Antibiotics |
| 09/21/2006 | US20060211629 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | US20060211013 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 09/21/2006 | US20060210593 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same |
| 09/21/2006 | US20060210587 Virus-like particles for the induction of autoantibodies |
| 09/21/2006 | US20060210565 Antagonists of HMG1 for treating inflammatory conditions |
| 09/21/2006 | US20060210528 Therapy for tropical diseases |
| 09/21/2006 | DE202006009610U1 Chitin, beta 1,3/1,6 D glucan and melanin bio spray, useful for fighting against foot fungus and simultaneous recovery of affected areas, comprises chitin, beta 1,3/1,6 D glucan and melanin complex, where the bio spray is a dry spray |
| 09/21/2006 | DE19681478B4 R-(-)-(E)-[4-(2,4-Dichlorphenyl)-1,3-dithiolan-2-yliden]-1-imidazolylacetonitril,Verfahren zu seiner Herstellung und seine Verwendung R - (-) - (E) - [4- (2,4-dichlorophenyl) -1,3-dithiolan-2-ylidene] -1-imidazolylacetonitril, process for its preparation and its use |
| 09/21/2006 | DE102005042875A1 Schnell freisetzende Darreichungsformen für Antibiotika Quick-release dosage forms of antibiotics |
| 09/21/2006 | DE102005012681A1 New 1,5-dihydro-pyrrol-2-one compounds are HDM2 inhibitors, useful for treating e.g. stroke, heart infarct, ischemia, multiple sclerosis, Alzheimer's disease, degenerative disease, viral infection and cancer |
| 09/21/2006 | CA2601115A1 Antibodies against candida antigens |
| 09/21/2006 | CA2600935A1 Use of copper silicate for the control of herpes infections |
| 09/21/2006 | CA2599667A1 Antimicrobial compositions comprising esters of hydroxy carboxylic acids |
| 09/21/2006 | CA2599653A1 Methods of reducing microbial contamination |
| 09/21/2006 | CA2599473A1 Antiviral compositions and methods of use |
| 09/20/2006 | EP1702983A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof |
| 09/20/2006 | EP1702927A1 Attenuated microorganisms for the treatment of infection |
| 09/20/2006 | EP1702926A1 Levulose glucoselipid a analogue |
| 09/20/2006 | EP1702921A1 Beta-lactamase-resistant cephalosporin ester compounds and salts of thereof |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702621A2 Metal/Thiol biocides |
| 09/20/2006 | EP1702617A1 Cannabimimetic indole derivatives |
| 09/20/2006 | EP1702613A1 Preventive for the onset of liver cancer comprising quinone compound as the active ingredient |
| 09/20/2006 | EP1701977A2 Sars coronavirus s proteins and uses thereof |
| 09/20/2006 | EP1701962A2 Rifamycin analogs and uses thereof |
| 09/20/2006 | EP1701942A1 Non-nucleotide reverse transcriptase inhibitors |
| 09/20/2006 | EP1701933A1 Novel compounds |
| 09/20/2006 | EP1701726A2 Antimicrobial photodynamic therapy compound and method of use |
| 09/20/2006 | EP1701720A1 Use of chp as an inhibitor of glutathione s-transferases and collagen iv |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1343797B1 Macrolide antibiotics |
| 09/20/2006 | EP1343780B1 Piperazine derivatives for treatment of bacterial infections |
| 09/20/2006 | EP1280897B1 Regulation of nf-at interacting protein nip 45 variant |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | EP1244627B1 Picolinic acid derivatives and their use as fungicides |
| 09/20/2006 | EP1171446B1 Macrolide antiinfective agents |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | EP0914153B1 Multivalent dtp-polio vaccines |
| 09/20/2006 | EP0799037B1 Compositions for treating allergic rhinitis and other disorders comprising descarboethoxyloratadine |
| 09/20/2006 | CN1835951A Isethionate salt of a selective CDK4 inhibitor |
| 09/20/2006 | CN1835765A Method of treating viral infections |
| 09/20/2006 | CN1835750A Oxime substituted imidazo-containing compounds |
| 09/20/2006 | CN1835744A Remedy for viral disease |
| 09/20/2006 | CN1834095A Nonnucleoside antivirus inhibitor, its prepn. and use |
| 09/20/2006 | CN1834090A Benzimidazole compounds, its prepn. and uses |
| 09/20/2006 | CN1834087A Organo-iodine complex |
| 09/20/2006 | CN1833723A Chain coccus recombination subunit vaccine and prepn. thereof |
| 09/20/2006 | CN1833721A Compsns. of thymopentin and interferon |
| 09/20/2006 | CN1833697A Expelling toxin opsonic water, opsonic pills and prepn. method thereof |
| 09/20/2006 | CN1833691A Externally used Chinese patent medicine for treating colpomycosisor tricho monal vaginitis, and prepn. method |
| 09/20/2006 | CN1833674A Wart gel and prepn. method |